TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines

Federico Martinón-Torres*, Xavier Bosch, Rino Rappuoli, Shamez Ladhani, Esther Redondo, Timo Vesikari, Adolfo García-Sastre, Irene Rivero-Calle, José Gómez-Rial, Antonio Salas, Carlos Martín, Adam Finn, Robb Butler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22–23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.

Original languageEnglish
Pages (from-to)2405-2415
Number of pages11
JournalHuman Vaccines and Immunotherapeutics
Issue number10
Publication statusPublished - 3 Oct 2019

Bibliographical note

Funding Information:
Medical writing support was provided by Dr. Almudena Fuster of Medical Statistics Consulting S.L. (Valencia). Editorial assistance was provided by Content Ed Net (Madrid, Spain). FMT and AS research activities received support from the Instituto de Salud Carlos III (Proyecto de Investigación en Salud, Acción Estratégica en Salud): project GePEM ISCIII/PI16/01478/Cofinanciado FEDER, and project ReSVinext ISCIII/PI16/01569/Cofinanciado FEDER; Consellería de Sanidade, Xunta de Galicia (RHI07/2-intensificación actividad investigadora, PS09749 and 10PXIB918184PR), Instituto de Salud Carlos III (Intensificación de la actividad investigadora 2007–2012, PI16/01569), Fondo de Investigación Sanitaria (FIS; PI070069/PI1000540) del plan nacional de I+D+I and ‘fondos FEDER’, and 2016-PG071 Consolidación e Estructuración REDES 2016GI-1344 G3VIP (Grupo Gallego de Genética Vacunas Infecciones y Pediatría, ED341D R2016/021). Research on flaviviruses at the AG-S laboratory is partially funded by NIAID grants R21AI129486, R21AI142337 and U19AI118610 Research on influenza virus vaccines and immunity at the AG-S laboratory is partly funded by NIAID grants U19AI117873, U01AI124297, R01AI127658, P01AI097092, U19AI135972, and R01 AI141226-01, by the Bill and Melinda Gates Foundations (OPP1084518), by a research contract from GSK and by CRIP (Center for Research on Influenza Pathogenesis), an NIAID funded Center of Excellence for Influenza Research and Pathogenesis (CEIRS, contract number HHSN272201400008C).

Publisher Copyright:
© 2019, © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.


  • infectious diseases
  • infectomics
  • vaccine hesitancy
  • vaccines
  • vaccinomics


Dive into the research topics of 'TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines'. Together they form a unique fingerprint.

Cite this